CAR T cells based on fully human T cell receptor-mimetic antibodies exhibit potent antitumor activity in vivo. - Salzler R; DiLillo DJ; Saotome K; Bray K; Mohrs K; Hwang H; Cygan KJ; Shah D; Rye-Weller A; Kundu K; Badithe A; Zhang X; et al. (Science translational medicine, 2025)